Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03090516
What this trial is testing

Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's
The First Affiliated Hospital with Nanjing Medical University 240
Testing effectiveness (Phase 2)Study completedNCT00479557
What this trial is testing

Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 86
Testing effectiveness (Phase 2)Study completedNCT01513967
What this trial is testing

SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease

Who this might be right for
Healthy VolunteersModerate to Severe Alzheimer Patients
Regenera Pharma Ltd 39
Not applicableUnknownNCT05343611
What this trial is testing

Chocolate and Physical Exercise to Reduce Malnutrition in Pre-dementia Aged People

Who this might be right for
DementiaDementia, MildDementia Moderate+4 more
Massimo Venturelli, PhD 102
Testing effectiveness (Phase 2)Study completedNCT01019421
What this trial is testing

Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 278
Early research (Phase 1)Ended earlyNCT03179501
What this trial is testing

NP001, Alzheimer's Disease, and Blood Markers of Inflammation

Who this might be right for
Alzheimer Disease
Beau Nakamoto 4
Testing effectiveness (Phase 2)Ended earlyNCT05478031
What this trial is testing

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
reMYND 14
Large-scale testing (Phase 3)Looking for participantsNCT07066826
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Dementia
Wanbangde Pharmaceutical Group Co., LTD 720
Testing effectiveness (Phase 2)Study completedNCT01764243
What this trial is testing

Safety and Efficacy of MT-4666

Who this might be right for
Alzheimer's Disease
Tanabe Pharma Corporation 450
Not applicableUnknownNCT05251649
What this trial is testing

Transcranial Alternating Current Stimulation Combined With 40Hz Sound Stimulation for Treatment Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Chinese PLA General Hospital 60
Large-scale testing (Phase 3)Study completedNCT00574132
What this trial is testing

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 1,331
Not applicableLooking for participantsNCT05048966
What this trial is testing

Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons

Who this might be right for
Traumatic Brain InjuryMild Traumatic Brain InjuryAlzheimer's Disease+3 more
Kessler Foundation 360
Early research (Phase 1)Study completedNCT05466422
What this trial is testing

MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 34
Post-approval studies (Phase 4)WithdrawnNCT01822951
What this trial is testing

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

Who this might be right for
Alzheimer Disease
Ever Neuro Pharma GmbH
Testing effectiveness (Phase 2)Study completedNCT00876863
What this trial is testing

Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sangamo Therapeutics 49
Testing effectiveness (Phase 2)Study completedNCT00112073
What this trial is testing

AAB-001 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 234
Testing effectiveness (Phase 2)Study completedNCT02244541
What this trial is testing

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 32
Large-scale testing (Phase 3)Study completedNCT00478205
What this trial is testing

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 1,467
Early research (Phase 1)Not Yet RecruitingNCT07554872
What this trial is testing

Study of Neural Stem Cell-Derived Exosomes in Moderate-to-Severe Early-Onset Alzheimer's Disease

Who this might be right for
Alzheimer Disease (AD)
Shanghai Mental Health Center 9
Testing effectiveness (Phase 2)Study completedNCT00752232
What this trial is testing

Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 40
Next Page